lobbying_activities: 965469

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
965469	3446857a-880a-4211-a214-8e58e0ee530d	Q2	AMYLIN PHARMACEUTICALS	308536	AMYLIN PHARMACEUTICALS	2010	second_quarter	PHA	Physician Payments Sunshine provision of Pub. L. 111-148 (Patient Protection and Affordable Care Act of 2010) FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues	HOUSE OF REPRESENTATIVES,SENATE		240000	0	0	2010-07-19T16:57:15.527000-04:00